These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16008893)

  • 1. [Management and prognosis of metastatic ovarian carcinoma from nongenital tract].
    Wu XF; Chen Y
    Zhonghua Fu Chan Ke Za Zhi; 2005 Jun; 40(6):404-6. PubMed ID: 16008893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
    Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
    Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathological features and prognosis of 68 patients with metastatic ovarian tumors from the gastric cancer].
    Zhao JZ; Wang G; Zhang RP; Liang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Feb; 13(2):129-32. PubMed ID: 20186624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnosis and treatment of recurrent epithelial ovarian carcinoma].
    Wu XF; Chen HZ; Han DF
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):664-6. PubMed ID: 14728851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive surgery for stage IV epithelial ovarian cancer.
    Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
    J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma.
    Liu EL; Mi RR
    Chin Med J (Engl); 2004 Oct; 117(10):1547-51. PubMed ID: 15498381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).
    Cheng X; Jiang R; Li ZT; Tang J; Cai SM; Zhang ZY; Tian WJ; Zang RY
    Eur J Surg Oncol; 2009 Oct; 35(10):1105-8. PubMed ID: 19443175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of metastasis to the ovaries from nongenital tract primary tumors.
    Moore RG; Chung M; Granai CO; Gajewski W; Steinhoff MM
    Gynecol Oncol; 2004 Apr; 93(1):87-91. PubMed ID: 15047218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How to increase the optimal rate of secondary cytoreductive surgery in recurrent epithelial ovarian cancer].
    Li YF; Li MD; Liu FY; Liu JH; Li JD
    Ai Zheng; 2003 Nov; 22(11):1193-6. PubMed ID: 14613651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cytoreductive surgery for colon cancer metastatic to the ovary.
    McCormick CC; Giuntoli RL; Gardner GJ; Schulick RD; Judson K; Ronnett BM; Vang R; Bristow RE
    Gynecol Oncol; 2007 Jun; 105(3):791-5. PubMed ID: 17408727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy.
    Matsumoto A; Higuchi T; Yura S; Mandai M; Kariya M; Takakura K; Fujii S
    J Obstet Gynaecol Res; 2006 Dec; 32(6):580-7. PubMed ID: 17100820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
    Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
    Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cytoreductive surgery for epithelial ovarian cancer.
    Hacker NF; Berek JS; Lagasse LD; Nieberg RK; Elashoff RM
    Obstet Gynecol; 1983 Apr; 61(4):413-20. PubMed ID: 6828269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytoreductive surgery in the management of stage IV epithelial ovarian cancer].
    Zang R; Zhang Z; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):197-9. PubMed ID: 11776157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian metastases from breast cancer: report of 29 cases.
    Bigorie V; Morice P; Duvillard P; Antoine M; Cortez A; Flejou JF; Uzan S; Darai E; Barranger E
    Cancer; 2010 Feb; 116(4):799-804. PubMed ID: 20041486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors affecting disease recurrence and the role of secondary therapies in the management for patients with recurrent ovarian carcinoma].
    Zang R; Zhang Z; Cai S
    Zhonghua Fu Chan Ke Za Zhi; 2002 Sep; 37(9):546-9. PubMed ID: 12411017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
    Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
    Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of second look laparotomy and secondary cytoreductive surgery at second-look laparotomy in ovarian cancer patients.
    Obermair A; Sevelda P
    Acta Obstet Gynecol Scand; 2001 May; 80(5):432-6. PubMed ID: 11328220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.